[ad_1]
Los Angeles, Calif .– (Newsfile Corp. – February 6, 2021) – Law firm Schall, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Minerva Neurosciences, Inc. (” Minerva “or” the Company “) (NASDAQ: NERV) for violations of §§ 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and rule 10b-5 promulgated by the Securities and Exchange Commission of United States.
Investors who purchased the securities of the Company between May 15, 2017 and November 30, 2020 inclusive (the “ Class Period ”) are encouraged to contact the Company prior to February 8, 2021.
If you are a shareholder with a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the company’s website at www.schallfirm.com or by email at [email protected].
The group, in this case, has not yet been certified, and until certification occurs, you are not represented by legal counsel. If you choose to do nothing, you can remain an absent group member.
According to the complaint, the company made false and misleading statements to the market. Minerva did not inform investors of the real FDA feedback after its “end of phase 2” meeting. The company’s Phase 2b study did not use the commercial formulation of roluperidone and was conducted exclusively outside of the United States. The company’s Phase 3 study was rendered unable to prove the drug’s efficacy due to failure to meet its primary and secondary endpoints. The combination of phase 2b and phase 3 trials would be “highly unlikely” to support an NDA submitted to the FDA. Based on these facts, the company’s public statements were false and materially misleading throughout the appeal period. When the market learned the truth about Minerva, investors suffered damage.
Join the case to recoup your losses.
Schall law firm represents investors around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered an advertisement for attorneys in certain jurisdictions under applicable law and ethical guidelines.
CONTACT:
Schall law firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73827
Source link
